NorthEast BioLab offers research oriented and fully regulated bioanalysis services from drug discovery to development.
NorthEast BioLab provides the full range of analytical, preclinical, and clinical method development plus sample analysis solutions.
We transfer validated methods from animal to human matrices during this phase. In addition to bioanalysis, we could provide central lab services such as custom kits and sample management to your clinical sites.
We handle the full breadth of your DMPK and dosage range studies using non-validated methods ahead of lead identification. Afterward, we perform method validation and sample analysis to conduct GLP Tox studies.
We offer biology and chemistry research for your target identification and validation, assay development, and lead optimization needs, and could help you demonstrate proof-of-concept (PoC).
We offer analytical testing for chemicals and biologics. Among other techniques, these bioanalytical solutions are provided using LC-MS/MS and ELISA Assay.
NorthEast BioLab believes in long-term partnership than transactional dealing for your critical bioanalysis. We systematically optimize your drug program through superior bioanalytical services at attractive resource and cost efficiencies. As the trusted bioanalysis experts for biotech, we even expand our role to include 3rd-party vendor management.
NorthEast BioLab’s primary value proposition is accelerated drug development through outstanding bioanalytical services. We have highly experienced bioanalysis talent to complement your in-house experts. Our regulatory knowledge, scientific excellence, and operational know-how help in taking your drug to the market quickly.
NorthEast BioLab intensively collaborates with customers to overcome scientific obstacles during their bioanalytical studies. Our scientists interface with clients directly to meet their stringent method development and sample analysis timelines. We commit to swift and accurate data reporting given the evolving nature of bioanalytics.
How long do you think it takes for a new drug to get approved in...
Bioanalysis is an essential tool in drug discovery and development for determining the concentration of...
It’s no secret that scientific research laboratories around the world aren’t exactly the most eco-friendly...
In an ideal scenario, a typical solution that is equally injected and then tested multiple...
Dried blood spot (DBS) analysis has been practiced for ~100 years[1], but has started gaining...
Bioanalytical assays are widely used to quantify drugs and their metabolites in a variety of...
NorthEast Biolab is by far the most responsive and thorough bioanalysis service provider. They work closely with the client to provide the most efficient and cost-effective approach to get the job done.
Our latest study together was a pivotal bioequivalence study, where samples from a cross-over study with about 100 volunteers needed swift analysis. This study, same as all other bioanalytical studies with NorthEast BioLab, was completed with very high quality and reporting standard and incredible responsiveness.
We have worked with NorthEast Biolab on several programs and have found them to be professional, collaborative, and responsive. As a small company, our vendors are key members of our project teams. The scientists at NorthEast Biolab are technical experts, who produce high-quality data, on-time, and on-budget.
Answers to bioanalysis and bioanalytical services questions popular among our potential clients.
Bioanalysis is a field of analytical and bioanalytical chemistry spanning the assessment of xenobiotics, biotics, and other analytes in biological matrices. In drug discovery and development, the role of bioanalytics is quantitation of drug compounds, metabolites, and biomarkers, etc. Extensive bioanalytical services such as pharmacokinetics (PK), toxicokinetics (TK), and bioequivalence of drugs are necessary during drug R&D to acquire the essential bioanalytical data.
Both! We offer small molecule bioanalysis utilizing LC-MS/MS, HPLC Fluorescence, and HPLC – UV. Our team has remarkable experience in PK sample analysis and TK safety testing using mass spectrometric and chromatographic bioanalytics.
Our large molecule bioanalysis consists of customized assays using ELISA, Luminex, and biology kits. Other bioanalytical lab capabilities include biomarker testing, cell-based assay, immunogenicity testing, biochemical assay, and Mechanism of Action (MoA) studies.
Both! We perform robust method development by optimizing sample preparation and instrument conditions as per targeted calibration curve and other bioanalysis parameters. Our veteran team is adept at method transfer to new bioanalytics personnel or equipment. We gladly modify your method for straightforward validation or if the transfer fails due to incomplete or incorrect information.
We run fit-for-purpose full three-day LC-MS/MS or six-day ELISA method validation to evaluate selectivity, specificity, sensitivity, precision, and accuracy. Here, we examine extraction recovery, carryover, matrix effect, and matrix suppression as well as ascertain process stability. We further assess the drug and biomarker stability during sample processing, analysis, and long-term storage.
NorthEast BioLab has provided bioanalytical services in 500+ studies for Investigational New Drug (IND), New Drug Application (NDA), Generics Application (ANDA), and Biologic License Application (BLA) filings with the US FDA. Our team of veteran scientists would help put together the budget and timeline for your bioanalysis needs. Contact NorthEast BioAnalytical Laboratories today to discuss your drug development projects.
Generally, we need just four weeks for bioanalytical services such as method development and validation following the purchase order. Afterward, we need ten days for submitting your audited bioanalytical lab report with complete details of validation experiments and a few batches of sample analysis data. Please note that turnaround times for your method set-up and sample analysis may vary based on i) Specific methods (e.g., chiral separation, extended run time/duplicate injection, assay with multiple analytes / metabolites), ii) Test article or formulation – large quantities, controlled substances, specific vehicles and iii) Other Materials – required columns, well plates, and materials/matrices.
Yes! NorthEast BioLab is registered with and has been audited by the US Food and Drug Administration (FDA) multiple times for good laboratory practices. We also keep our registrations in good standing with the United States Drug Enforcement Administration (DEA) and the Connecticut State Department of Consumer Protection.
Our clients can rest assured that we are in full compliance with all relevant industry regulations, e.g., FDA validation guidance and ICH guidelines for method validation. By stringently following these regulations, Northeast BioAnalytical Laboratories seamlessly completes each study that we accept. Please contact us if you would like additional proof or documentation of our credentials and certifications.
As your trusted bioanalytical lab, NorthEast BioLab flexibly partners with a vast network of affiliates to deliver requested analytical testing, preclinical, and clinical CRO solutions. With us, you’ll not only get access to first-class, client-focused bioanalytical services but also recommendations for preferred life sciences consultants and in-vivo, pathology, and materials providers. Speak with our veteran team to get head-start on your study and beat competitors to market.
